MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
This report contains market size and forecasts of Micro-RNA Sequencing and Assay in Global, including the following market information:
Global Micro-RNA Sequencing and Assay Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Micro-RNA Sequencing and Assay market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sequencing by Synthesis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Micro-RNA Sequencing and Assay include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Micro-RNA Sequencing and Assay companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Micro-RNA Sequencing and Assay Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Micro-RNA Sequencing and Assay Market Segment Percentages, by Type, 2021 (%)
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Global Micro-RNA Sequencing and Assay Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Micro-RNA Sequencing and Assay Market Segment Percentages, by Application, 2021 (%)
Research Institute
Academia
CRO
Global Micro-RNA Sequencing and Assay Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Micro-RNA Sequencing and Assay Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Micro-RNA Sequencing and Assay revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Micro-RNA Sequencing and Assay revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB